PEBP1 and neoplasm: Further studies have shown that RKIP role is tumor-type specific, and in most cancer types, such as colorectal carcinoma, gastric adenocarcinoma, hepatocellular carcinoma, and GISTs loss of RKIP expression is linked to advanced tumor stages and worse clinical outcome [25]–[32].